Nuveen Asset Management, LLC Innoviva, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 163,676 shares of INVA stock, worth $2.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,676

Previous 163,676 -0.0%

Holding current value

$2.89 Million

Previous $2.68 Million 17.66%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$14.4 - $16.4 $3.31 Million - $3.77 Million	-229,672 Reduced 58.39%	163,676 $2.68 Million
Q1 2024 May 13, 2024	SELL	$14.56 - $16.78 $1.31 Million - $1.52 Million	-90,291 Reduced 18.67%	393,348 $5.99 Million
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $56,043 - $74,012	-4,549 Reduced 0.93%	483,639 $7.76 Million
Q3 2023 Nov 14, 2023	BUY	$12.37 - $13.89 $851,723 - $956,382	68,854 Added 16.42%	488,188 $6.34 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $24,488 - $29,498	2,150 Added 0.52%	419,334 $5.34 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $876,351 - $1.11 Million	-81,673 Reduced 16.37%	417,184 $4.69 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $1.41 Million - $1.65 Million	-119,587 Reduced 19.34%	498,857 $6.61 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $4.02 Million - $5.27 Million	-346,071 Reduced 35.88%	618,444 $7.18 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $2.95 Million - $4.1 Million	206,167 Added 27.19%	964,515 $14.2 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $439,907 - $578,826	28,584 Added 3.92%	758,348 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.1 Million - $1.29 Million	68,955 Added 10.43%	729,764 $12.3 Million
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $2.62 Million - $3.45 Million	200,395 Added 43.52%	660,809 $10.3 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $132,785 - $161,894	11,597 Added 2.58%	460,414 $6.17 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $698,372 - $812,663	-63,144 Reduced 12.33%	448,817 $5.36 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $12,166 - $16,273	1,304 Added 0.26%	511,961 $6.34 Million
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $98,579 - $138,278	-9,543 Reduced 1.83%	510,657 $5.34 Million
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $599,755 - $796,541	-52,198 Reduced 9.12%	520,200 $7.27 Million
Q1 2020 May 14, 2020	SELL	$8.11 - $15.23 $183,415 - $344,441	-22,616 Reduced 3.8%	572,398 $6.73 Million
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $207,429 - $290,159	20,178 Added 3.51%	595,014 $8.43 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $22,702 - $32,868	2,259 Added 0.39%	574,836 $6.06 Million
Q2 2019 Aug 15, 2019	BUY	$13.1 - $14.95 $7.5 Million - $8.56 Million	572,577 New	572,577 $8.34 Million

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.23B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Innoviva, Inc. Transaction History